Feasibility of CALM in Patients With Ovarian Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity Health Network, Toronto
About this trial
The goal of this feasibility trial is to determine the feasibility and acceptability of implementing a brief evidence-based psychotherapeutic intervention, Managing Cancer And Living Meaningfully (CALM), at the time of a new diagnosis and recurrence of ovarian cancer (OC).
The main questions are:
1. Is it feasible and acceptable to implement CALM for patients with newly diagnosed or recently recurred advanced OC 2. What are the prevalence and correlates of traumatic stress symptoms at baseline in patients with newly diagnosed or recently recurred advanced OC
Participants will be asked to complete questionnaires at baseline and at 3 and 6 months following a diagnosis or recurrence of stage III or IV OC. Participants will also be invited to participate in 3-6 sessions of CALM therapy.
Eligibility criteria
Qualifiers
new diagnosis or recurrence of stage III or stage IV OC;
age ≥18 years
able to complete outcome measures and engage in CALM in English.
Disqualifiers
evidence of cognitive impairment indicated in the medical record, communicated by the OC clinic team, or determined by research staff at recruitment;
receiving psychological or psychiatric counseling from the Department of Supportive Care at PM at the time of recruitment.
Trial design
Treatments tested in this trial
- Managing Cancer And Living Meaningfully (CALM)
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
University Health Network, Toronto
Lead sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator
Source ClinicalTrials.gov